JNJ Halts COVID Vaccine Trial Triggering A Selloff

Commenting on Johnson & Johnson halting its COVID vaccine trial and today’s trading Gorilla Trades strategist Ken Berman said:Q3 2020 hedge fund letters, conferences and moreJohnson & Johnson Halts COVID Vaccine TrialThe major indices are mixed and flat at midday on the heels of a choppy morning session as U.S. stocks settled down following four bullish sessions in a row. Johnson & Johnson (JNJ, -2.1%) announced that halted its promising COVID vaccine trial due to an unexplained sickness affecting one patient, which triggered a selloff in the hardest-hit industries. Global risk assets got hit …

Read More

HEDGE accordingly